FIELD: psychiatry and neurology.
SUBSTANCE: first, epileptogenesis state and, additionally, immunologic factors are assessed. If immunodeficiency is found, two cyclopherone treatment courses are performed. Medication is injected intramuscularly, starting with 250 mg once a day over a 5-day period and following 10 injections are performed every second day. Treatment course is repeated after 2 month interval.
EFFECT: increased reliability of diagnostics and preclinical epilepsy phase treatment efficiency.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING PRE-CLINICAL STAGE OF EPILEPSY | 2003 |
|
RU2246727C2 |
| METHOD FOR DIAGNOSTICS AND PREDICTION OF EPILEPSY DEVELOPMENT IN PATIENTS AT PRECLINICAL STAGE OF THE DISEASE | 2001 |
|
RU2188575C1 |
| METHOD OF NEUROIMMUNE DISORDER DIAGNOSTICS | 2006 |
|
RU2329762C2 |
| METHOD FOR DIAGNOSING AND PREDICTING EPILEPSY DEVELOPMENT IN PATIENTS AT PRECLINICAL DISEASE STAGE | 2001 |
|
RU2189776C1 |
| METHOD OF PREVENTING GESTATIONAL COMPLICATIONS IN PREGNANT WOMEN WITH EPILEPSY | 2017 |
|
RU2657772C1 |
| METHOD FOR LYMPHOSTIMULATION AND IMMUNOMODULATION IN CEREBROSPINAL SCLEROSIS | 2003 |
|
RU2246942C2 |
| METHOD FOR PREDICTING ORGANISM RESISTANCE TO STRESS ACTION | 2006 |
|
RU2322675C1 |
| METHOD FOR PREDICTING IMMUNODEFICIENT STATE IN PATIENTS WITH CEREBRAL ORGANIC DISEASES AT CONVULSIVE SYNDROME | 2006 |
|
RU2310390C1 |
| METHOD OF COMPLEX IMMUNOMODULATING TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION | 2010 |
|
RU2422136C1 |
| METHOD FOR PREDICTING DIFFERENT STAGES OF EPILEPTOGENESIS | 2004 |
|
RU2297791C2 |
